Results 241 to 250 of about 17,487,572 (398)
ABSTRACT Objective Alexander disease (AxD) is a severe neurodegenerative disorder caused by gain‐of‐function mutations in the gene for GFAP, which lead to protein aggregation and a primary astrocytopathy. Symptoms vary, but failure to thrive (FTT) and frequent emesis are common and cause significant morbidity. Here we investigate GDF15, a member of the
Tracy L. Hagemann +6 more
wiley +1 more source
Evaluation of water quality and soil fertility in remediated farmland for protection of wetland ecology by planting different crops. [PDF]
Liu C +9 more
europepmc +1 more source
Monitoring the Water Quality Distribution Characteristics in the Huaihe River Basin Based on the Sentinel-2 Satellite [PDF]
Xuanshuo Shi +8 more
openalex +1 more source
COVID-19 and surface water quality: Improved lake water quality during the lockdown
Ali. P. Yunus, Y. Masago, Y. Hijioka
semanticscholar +1 more source
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini +13 more
wiley +1 more source
Relapsing–Remitting Multiple Sclerosis Is Associated With a Dysbiotic Oral Microbiome
ABSTRACT Objective Multiple sclerosis (MS) is a chronic autoimmune disorder characterized by inflammation, demyelination, and neurological impairment. While the gut microbiota's role in MS is extensively studied, the association between the oral microbiota and MS remains underexplored, particularly in North American cohorts.
Sukirth M. Ganesan +12 more
wiley +1 more source
Decoding water quality across urban and rural dental clinics: insights from an observational study. [PDF]
Vatanparast B +3 more
europepmc +1 more source
Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin +2 more
wiley +1 more source
Development of Autonomous Electric USV for Water Quality Detection. [PDF]
Chen CH, Shang YJ, Wu YC, Lin YC.
europepmc +1 more source

